IPS cells are successfully treated for latoxia.

According to a study at Kyoto University, it is reported that diabetes therapy by using rats as cell transplants has succeeded.

And that's what we're going to do.

The treatment regarding cell transplants, which is considered very risky even in diabetes therapy.

This is a study that has been made over all of the problems that have come up with not many rejections, autoimmune reactions, other side effects, and pancreatic Island.

I'm not sure if we're going to get rid of the pancreatic island lack.

While we're treating people, it's still important to have donors.
But it must be more expected of the health industry that this treatment, which was difficult because it was not so easy to get in, has increased the likelihood that thanks to the IPPS cells, it has greatly increased the chances that this treatment will be possible from such a lack of pancreatic land.
Source:qlifepro